Acta Pharmaceutica Sinica B
|
2025, 15(10): 5231-5243
• Original articles •
Divergent activation patterns of BRS3 revealed by two Chinese herb-derived agonists
Full
Jie Li1,1,1,1, Changyao Li2,3,1,1, Qingtong Zhou4, Wei Han4, Mingzhu Fang5, Youwei Xu1,1, Yiting Mai6, Yao Zhang1,1,1,1, Jiahua Cui7, H. Eric Xu2,4,8,1,1, Yan Zhang5, Wanchao Yin8,9,1,1, Ming-Wei Wang4,6,10,1,1,1,1,1
Affiliations
1 2. Department of Chemistry, School of Science, the University of Tokyo, Tokyo 113-0033, Japan;
2 School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China;
3 Lingang Laboratory, Shanghai 200031, China;
4 Research Center for Medicinal Structural Biology, National Research Center for Translational Medicine at Shanghai, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China;
5 Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai 200240, China;
6 Research Center for Deepsea Bioresources, Sanya 572025, China;
7 School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China;
8 University of Chinese Academy of Sciences, Beijing 100049, China;
9 0. Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China;
10 1. Engineering Research Center of Tropical Medicine Innovation and Transformation of Ministry of Education, School of Pharmacy, Hainan Medical University, Haikou 570228, China
doi: 10.1016/j.apsb.2025.06.025
Outline
Bombesin receptor subtype-3 (BRS3) is an orphan G protein-coupled receptor (GPCR) that plays critical roles in energy homeostasis, glucose metabolism, and insulin secretion. Recent structural studies have elucidated BRS3 signaling mechanisms using synthetic ligands, including BA1 and MK-5046. However, the molecular basis of BRS3 activation by bioactive natural compounds and their derivatives, particularly those derived from traditional Chinese medicine, remains unclear. Here, we present high-resolution cryogenic electron microscopy (cryo-EM) structures of the human BRS3-Gq complex in both unliganded and active states bound by two herb-derived compounds (DSO-5a and oridonin), at resolutions of 2.9, 2.8, and 2.9 Å, respectively. These structures display distinct ligand recognition patterns between DSO-5a and oridonin. Although both compounds bind to the orthosteric pocket, they differentially engage the interaction network of BRS3, as demonstrated by mutagenesis studies assessing calcium mobilization and inositol phosphate 1 (IP1) accumulation. These findings enhance our understanding of BRS3 activation and provide valuable insights into the development of small-molecule BRS3 modulators with therapeutic potential.
Bombesin receptor subtype-3
/
Cryo-EM
/
Structural pharmacology
/
Unliganded
/
Chinese herb DSO-5a
/
Oridonin
/
Receptor activation
/
Drug discovery
Jie Li, Changyao Li, Qingtong Zhou, Wei Han, Mingzhu Fang, Youwei Xu, Yiting Mai, Yao Zhang, Jiahua Cui, H. Eric Xu, Yan Zhang, Wanchao Yin, Ming-Wei Wang.
Divergent activation patterns of BRS3 revealed by two Chinese herb-derived agonists[J].
Acta Pharmaceutica Sinica B,
2025
, 15
(10)
: 5231
-5243
.
DOI: 10.1016/j.apsb.2025.06.025
Year 2025 volume 15 Issue 10
PDF
8
5
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2025.06.025
- Receive Date:2025-02-25
- Online Date:2026-09-17